Comparison of Long-Term Outcomes Between Ipsilateral and Bilateral Central Neck Dissection in Occult Contralateral Central Lymph Metastasis in Papillary Thyroid Carcinoma With Unilateral Lateral Neck Metastasis Using Propensity Score Matching

This study aimed to evaluate long-term prognosis of contralateral central neck dissection in papillary thyroid cancer (PTC) patients with ipsilateral lateral neck metastasis. We aimed to produce clinical evidence to help determine the extent of central neck dissection (CND) focusing on the separation between the ipsilateral and contralateral sides. A total of 708 PTC patients who underwent total thyroidectomy and concomitant ipsilateral or bilateral CND with ipsilateral lateral neck dissection (LND) were retrospectively included between January 1997 and December 2015 at a single institution. The median follow-up time was 89.7 months, the mean age was 44.7 years and the mean tumor size was 1.5 cm. Among the study population, 507 were female (71.5%) and 201 (28.5%) were male. Locoregional recurrence (LRR) was observed in 26 (7.9%) patients and 30 (7.9%) patients in the ipsilateral and bilateral CND groups, respectively. There were 6 (1.8%) contralateral recurrence cases in the ipsilateral CND group and 5 (1.3%) cases in the bilateral CND group. Male sex (adjusted HR = 1.857, p = 0.034), larger tumor size (adjusted HR = 4.298, p = 0.006), and more metastatic ipsilateral central lymph nodes (adjusted HR = 1.078, p = 0.014) significantly increased the risk of LRR. Ipsilateral CND only did not significantly increase the risk of LRR (adjusted HR = 1.110, p = 0.712). There were no significant differences in recurrence according to contralateral central neck dissection status after propensity score matching (p = 0.424), either. The incidence of hypocalcemia (p = 0.007) was higher in the bilateral CND group compared to the ipsilateral CND group. Surgeons may consider performing contralateral CND only for therapeutic purposes to reduce unnecessary complications.

[1]  Jee Soo Kim,et al.  Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis. , 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  Xiaoyun Liu,et al.  Evolutionary features of thyroid cancer in patients with thyroidectomies from 2008 to 2013 in China , 2016, Scientific Reports.

[3]  Jeong Hyun Lee,et al.  Recent Changes in the Clinical Outcome of Papillary Thyroid Carcinoma With Cervical Lymph Node Metastasis. , 2015, The Journal of clinical endocrinology and metabolism.

[4]  Chieh-Hsi Wu,et al.  A population‐based nested case–control study: the use of 5‐alpha‐reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia , 2015, Clinical endocrinology.

[5]  P. Vitti,et al.  Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. , 2015, The Journal of clinical endocrinology and metabolism.

[6]  A. Rizzuto,et al.  Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study , 2013, BMC Surgery.

[7]  S. Mandel,et al.  The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. , 2012, Thyroid : official journal of the American Thyroid Association.

[8]  P. Peduzzi,et al.  American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.

[9]  J. Roh,et al.  Central Lymph Node Metastasis of Unilateral Papillary Thyroid Carcinoma: Patterns and Factors Predictive of Nodal Metastasis, Morbidity, and Recurrence , 2011, Annals of Surgical Oncology.

[10]  E. Choi,et al.  Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck. , 2010, Journal of the American College of Surgeons.

[11]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[12]  T. Fahey,et al.  Impact of Prophylactic Central Neck Lymph Node Dissection on Early Recurrence in Papillary Thyroid Carcinoma , 2010, World Journal of Surgery.

[13]  D. Steward,et al.  The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. , 2009, Thyroid : official journal of the American Thyroid Association.

[14]  J. Chung,et al.  Extent of Prophylactic Lymph Node Dissection in the Central Neck Area of the Patients with Papillary Thyroid Carcinoma: Comparison of Limited Versus Comprehensive Lymph Node Dissection in a 2-Year Safety Study , 2008, Annals of Surgical Oncology.

[15]  J. Roh,et al.  Lateral Cervical Lymph Node Metastases from Papillary Thyroid Carcinoma: Pattern of Nodal Metastases and Optimal Strategy for Neck Dissection , 2008, Annals of Surgical Oncology.

[16]  J. Jimeno,et al.  Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. , 2005, Surgery.

[17]  E. Baudin,et al.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.

[18]  Bruno D Fornage,et al.  Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. , 2003, Surgery.

[19]  C. Sagan,et al.  Localization of Cervical Node Metastasis of Papillary Thyroid Carcinoma , 1999, World Journal of Surgery.

[20]  R. Bergamaschi,et al.  Morbidity of thyroid surgery. , 1998, American journal of surgery.

[21]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[22]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[23]  T. Fahey A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer , 2012 .

[24]  R. Hinze,et al.  Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer , 2001, World Journal of Surgery.

[25]  I. Hay,et al.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. , 1996, Surgical oncology clinics of North America.